Searched for
TAKASHI NOMURA
Japan stocks extend fall as lockdown worries returnThe Nikkei 225 Index ended down 2.04 per cent at 28,405.52. The broader Topix fell 2.18 per cent to 1,928.58, posting its biggest daily per...
Japan shares gain as optimism around corporate earnings growsThe Nikkei index closed up 0.97 per cent at 28,362.17 points, with consumer goods, materials makers and real estate companies leading gains...
Nikkei ends at three-decade high on tech, brokerage shares boostThe Nikkei index ended 0.85 per cent higher at 28,698.26, while the broader Topix rose for a sixth straight session to end 0.48 per cent hi...
Nikkei hits near 3-week low on fears of second coronavirus waveOn the Nikkei index, there were 5 advancers against 219 decliners, with cyclical shares leading the losses.
Japan's debt mountain: How is it sustainable?Japan's debt began to swell in the 1990s when its finance and real estate bubble burst to disastrous effect. With stimulus packages and a r...
What could an Olympics postponement cost Japan?Toshiro Muto, CEO of Tokyo 2020, asked about how much delaying the games will cost Japan, said: "The basic policy of postponement was decid...
Nikkei ends higher as defensive stocks rallyThe Nikkei share average gained 0.5 per cent to 21,556.51, not far from its more than 10-week high.
Japan's Nikkei dips on investor caution, Topix buoyed by BoJ talkThe Nikkei has recovered roughly 8 per cent from an eight-month low at the end of December.
Indian bonds set to outshine emerging market peers: Nomura AMCIndia’s benchmark 10-year yield has climbed to the highest level since 2014 last month.
Japan's Kose enters India with new brand SpawakeAt present, Spawake products' targeted at urban women will be made by a contract manufacturer, but the company may look at setting up a fac...
- Tryst in Tokyo led to Daiichi, Ranbaxy union
The Japanese company planned to run a full-fledged operations in India and had long-terms plans for India.
- Daiichi snaps up Ranbaxy for $4.6 bn
A marauding Corporate India watched in stunned disbelief that the promoters of Ranbaxy were actually selling out.
- Hoya waits for a clear picture on Pentax bid
Pentax is indecisively chewing over a sweetened takeover bid from Hoya in a gamble that could risk sinking the deal if the profitable high-...